showed that serous ovarian cancer had a significantly higher BRCA1 hypermethylation frequency compared to non-serous ovarian cancer, but there was no significant correlation between BRCA1 hypermethylation and age32. This evidence concerns the gene BRCA1 and ovarian serous adenocarcinoma.